Its harmless and often used in ultra-high doses
Cagrilintide + Semaglutide, 10 mg Blend (single combined vial) One 10 mg blend vial reconstituted at 3.0 mL covers the full titration
The effect on stroke is remarkable (and was significant in the trials of both semaglutide and dulaglutide), amounting to an 18% risk reduction, also because the other class of new antidiabetic agents with cardiovascular benefits, the SGLT2-inhibitors, show no a similar effect on stroke (but do have a significant effect on heart failure) [24]
The daily dose is 1.28 mg , drawn as 0.16 mL , injected once a day under the skin of the abdomen
Studies analyzing Meibomian gland probing (MGP) focusing on the procedures safety and efficacy have been conducted in the United States, Mexico, China, Russia, Cuba, Turkey, India, and Japan with peer reviewed articles having been published supporting the effectiveness of MGP for patients refractory to standard care as a first-line treatment for Meibomian gland dysfunction